Back to top

Analyst Blog

We recently reiterated our Neutral recommendation on Life Technologies Corporation , a global biotechnology tools company. While we hold a favorable view regarding Life Technologies’ Genetic Analysis sales that received a strong boost from the Ion Torrent franchise; economic uncertainties lowering discretionary spending, NIH funding cut and unfavorable currency were the major headwinds for the company during the reported quarter. The stock currently carries a Zacks Rank #3 (Hold).

Why at Neutral?

Life Technology’s fourth-quarter adjusted earnings per share (EPS) of $1.11 remained in line with the Zacks Consensus Estimate but were down 5.7% year over year. Adjusted revenues increased 4.5% at CER to $999 million, ahead of the Zacks Consensus Estimate of $990 million.

Life Technologies enjoys a strong position in the life sciences market and we are impressed with the strong momentum of its Ion Torrent franchise. Moreover, the company is working on expanding its portfolio with several product launches.

In Feb 2013, a dozen new products for the Ion Torrent platform were launched, aimed at expanding clinical research across the globe.These new products enabled the Ion Torrent semiconductor sequencing technology to expand 1,000-fold in just 2 years and gain a 60% market share of benchtop sequencers.

Also, the recent acquisitions of BAC BV, Navigenics, Pinpoint Genomics and Compendia along with new distribution agreements in China and Chile would enable the company strengthen its diagnostics franchise and extend its footprint in emerging markets.

However, Life Technology’s exposure to the U.S. government funding is somewhere between 10% and 15%, depending on the level of funding. The recent sequestration cuts (implemented with effect from Jan 2, 2013) that curbed the NIH (National Institutes of Health) budget by 8% are expected to restrict the company from opting for medical innovations. Based on the NIH budget cut, the company provided a conservative 2013 outlook.

Other Stocks to Consider

While we prefer to remain on the sidelines on Life Technologies, other medical device stocks worth a look are Medical Action Industries Inc. , Given Imaging Ltd. and Acadia Health Company Inc. (ACHC - Snapshot Report). All these stocks carry a Zacks Rank #1 (Strong Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
QIHOO 360 T… QIHU 95.04 +4.95%
PILGRIM'S P… PPC 31.52 +3.72%
CLAYTON WIL… CWEI 138.97 +3.55%
CALLON PETE… CPE 11.50 +3.14%
ACTELION LT… ALIOF 124.80 +2.97%